Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alendronate for low bone mineral density and vascular calcification in renal transplant recipients
jRCT1091220155Completed
- Sponsor
- Masanori Okamoto
- Start
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of alendronate in secondary osteoporosis, None, arterial calcification and 1 more, sponsored by Masanori Okamoto. Primary endpoints: Bone mineral density and Aortic calcification index. Started Dec 2013; status: completed.
02
Drugs
alendronate
03
Conditions
secondary osteoporosisarterial calcificationCalcific aortic valve disease (CAVD)
Beyond the preview
Go deeper on jRCT1091220155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1091220155.